Trial Profile
A Pilot Study of Hemoporfin Photodynamic Therapy in Children (7-14 Years Old) With Port-wine Stain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Aug 2020
Price :
$35
*
At a glance
- Drugs Hematoporphyrin monomethyl ether (Primary)
- Indications Port-wine stain
- Focus Therapeutic Use
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- 12 Aug 2020 Status changed from recruiting to completed.
- 13 Feb 2019 Planned End Date changed from 1 Dec 2018 to 1 Feb 2020.
- 13 Feb 2019 Planned primary completion date changed from 1 Dec 2018 to 1 Feb 2020.